RESEARCH TRIANGLE PARK, N.C. - March 13, 2001 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced today that U.S. District Court Judge Terrence W. Boyle extended to 5 p.m. on March 16 a previous temporary order requiring WebMD to make a complete delivery of data to Quintiles. Judge Boyle is scheduled to hear Quintiles' motion for a preliminary injunction on Friday, March 16, at 4 p.m.
Pharmaceutical companies, governments and healthcare organizations rely on the uninterrupted flow of these data for a variety of purposes, including public health screening; analyzing disease prevalence trends and treatment patterns; identification of disease "clusters" in geographic regions; and drug safety surveillance.
Quintiles Transnational is the world's leading provider of information, technology and services to bring new medicines to patients faster and improve healthcare. Headquartered near Research Triangle Park, North Carolina, Quintiles employs a global workforce of 18,000 in 39 countries. Quintiles Transnational is a member of the S&P 500 and Fortune 1000. For more information visit the company's Web site at www.quintiles.com.
Information in this press release contains "forward-looking statements" about Quintiles. These statements involve risks and uncertainties that could cause actual results to differ materially, including without limitation, our ability to complete development and commercialization of new products, the cost and timing of bringing new products to market compared with revenues which may be generated by them, market acceptance, that the court may not grant our motion for a preliminary injunction or may do so on terms less favorable than we requested, our data products business remains subject to state and federal laws and regulations, and we continue to rely on compliance from WebMD under the Data Rights Agreement to supply us data. Additional factors that could cause actual results to differ materially, including with respect to data products, are discussed in the company's recent filings with the Securities and Exchange Commission, including but not limited to its S-3 and S-4 Registration Statements, its Annual Report on Form 10-K, its Form 8-Ks, and its other periodic reports, including Form 10-Qs.